According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

A recently approved twice-yearly injection to prevent HIV may warrant a higher price, but thousands of dollars more?  CVS Caremark’s chief medical officer calls on Gilead Sciences to lower the $28,000 ...

South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

Officials said the first case emerged when a patient, who had received a blood transfusion on September 13, tested HIV ...

The matter first came to the light on Friday after a seven-year-old child suffering from thalassemia was transfused with ...

South Africa has welcomed a U.S. bridging plan worth $115 million to continue funding HIV treatment and prevention programs ...

According to a doctor, other factors, such as exposure to contaminated needles, could also lead to HIV infections.

A medical probe has been launched in Jharkhand’s Chaibasa after multiple thalassaemia children tested HIV-positive, allegedly ...

Several observational analyses suggest higher cardiovascular and dementia risks in those with and without HIV who get ...